Mesotten D - Search Results

1

Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study.

Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G. Vlasselaers D, et al. Among authors: mesotten d. Lancet. 2009 Feb 14;373(9663):547-56. doi: 10.1016/S0140-6736(09)60044-1. Epub 2009 Jan 26. Lancet. 2009. PMID: 19176240 Clinical Trial.

2

Regulation of insulin-like growth factor binding protein-1 during protracted critical illness.

Mesotten D, Delhanty PJ, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van Den Berghe G. Mesotten D, et al. J Clin Endocrinol Metab. 2002 Dec;87(12):5516-23. doi: 10.1210/jc.2002-020664. J Clin Endocrinol Metab. 2002. PMID: 12466347 Clinical Trial.

3

Clinical potential of insulin therapy in critically ill patients.

Mesotten D, Van den Berghe G. Mesotten D, et al. Drugs. 2003;63(7):625-36. doi: 10.2165/00003495-200363070-00001. Drugs. 2003. PMID: 12656643 Review.

4

Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy.

Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G. Mesotten D, et al. J Clin Endocrinol Metab. 2004 Jan;89(1):219-26. doi: 10.1210/jc.2003-030760. J Clin Endocrinol Metab. 2004. PMID: 14715853 Clinical Trial.

5

Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness.

Mesotten D, Wouters PJ, Peeters RP, Hardman KV, Holly JM, Baxter RC, Van den Berghe G. Mesotten D, et al. J Clin Endocrinol Metab. 2004 Jul;89(7):3105-13. doi: 10.1210/jc.2003-032102. J Clin Endocrinol Metab. 2004. PMID: 15240578 Clinical Trial.

6

Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients.

Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Vanhorebeek I, et al. Among authors: mesotten d. Lancet. 2005 Jan 1-7;365(9453):53-9. doi: 10.1016/S0140-6736(04)17665-4. Lancet. 2005. PMID: 15639679

7

Changes within the GH/IGF-I/IGFBP axis in critical illness.

Mesotten D, Van den Berghe G. Mesotten D, et al. Crit Care Clin. 2006 Jan;22(1):17-28, v. doi: 10.1016/j.ccc.2005.09.002. Crit Care Clin. 2006. PMID: 16399017 Review.

8

Changes within the growth hormone/insulin-like growth factor I/IGF binding protein axis during critical illness.

Mesotten D, Van den Berghe G. Mesotten D, et al. Endocrinol Metab Clin North Am. 2006 Dec;35(4):793-805, ix-x. doi: 10.1016/j.ecl.2006.09.010. Endocrinol Metab Clin North Am. 2006. PMID: 17127147 Review.

9

The altered adrenal axis and treatment with glucocorticoids during critical illness.

Mesotten D, Vanhorebeek I, Van den Berghe G. Mesotten D, et al. Nat Clin Pract Endocrinol Metab. 2008 Sep;4(9):496-505. doi: 10.1038/ncpendmet0921. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18695699 Review.

10

Bench-to-bedside review: metabolism and nutrition.

Casaer MP, Mesotten D, Schetz MR. Casaer MP, et al. Among authors: mesotten d. Crit Care. 2008;12(4):222. doi: 10.1186/cc6945. Epub 2008 Aug 19. Crit Care. 2008. PMID: 18768091 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters